|
C9ORF129 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.89277999999016E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.592100E-04 |
| Normal-vs-Stage2 |
5.057300E-03 |
| Normal-vs-Stage3 |
1.56260999999436E-05 |
| Normal-vs-Stage4 |
1.54781999999187E-05 |
| Stage1-vs-Stage2 |
8.562400E-01 |
| Stage1-vs-Stage3 |
2.251000E-01 |
| Stage1-vs-Stage4 |
1.065190E-01 |
| Stage2-vs-Stage3 |
3.020800E-01 |
| Stage2-vs-Stage4 |
1.813200E-01 |
| Stage3-vs-Stage4 |
6.428800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.77289999999864E-05 |
| Normal-vs-AfricanAmerican |
2.677600E-02 |
| Normal-vs-Asian |
4.419300E-04 |
| Caucasian-vs-AfricanAmerican |
5.488800E-01 |
| Caucasian-vs-Asian |
6.108200E-01 |
| AfricanAmerican-vs-Asian |
3.904600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.40929999999473E-05 |
| Normal-vs-Female |
4.47410000000703E-05 |
| Male-vs-Female |
3.282800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.359800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.90769999997009E-06 |
| Normal-vs-Age(61-80Yrs) |
4.02760000000058E-05 |
| Normal-vs-Age(81-100Yrs) |
2.587700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.920100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.489800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.198600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.196200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.626400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.966400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.089800E-01 |
| Classical-VS-Follicular |
1.862370E-01 |
| Classical-VS-Other |
1.029200E-01 |
| Classical-VS-Normal |
4.200600E-04 |
| Tall-VS-Follicular |
5.128400E-01 |
| Tall-VS-Other |
3.603000E-01 |
| Tall-VS-Normal |
9.72399999999984E-05 |
| Follicular-VS-Other |
2.676600E-01 |
| Follicular-VS-Normal |
1.404110E-04 |
| Other-VS-Normal |
2.317400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.009610E-04 |
| Normal-vs-N1 |
1.98284999999299E-05 |
| N0-vs-N1 |
1.597980E-01 |
|
|
